Steven Weber - 07 Nov 2024 Form 4 Insider Report for IGM Biosciences, Inc. (IGMS)

Role
PRINCIPAL ACCOUNTING OFFICER
Signature
/s/ Misbah Tahir, by power of attorney
Issuer symbol
IGMS
Transactions as of
07 Nov 2024
Net transactions value
$0
Form type
4
Filing time
12 Nov 2024, 19:19:50 UTC
Previous filing
17 Sep 2024
Next filing
18 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IGMS Common Stock Award $0 +6,700 +26% $0.000000 32,243 07 Nov 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 35% of the RSUs shall vest on January 13, 2025 and 65% of the RSUs shall vest November 10, 2025, provided that the Reporting Person remains a service provider through each vesting date.